The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
TLR-4 激动剂佐剂 GLA-SE 可改善 ID93 结核病疫苗引发的免疫反应的强度和质量：首次人体试验
期刊:NPJ Vaccines
影响因子:6.9
doi:10.1038/s41541-018-0057-5
Rhea N Coler, Tracey A Day, Ruth Ellis, Franco M Piazza, Anna Marie Beckmann, Julie Vergara, Tom Rolf, Lenette Lu, Galit Alter, David Hokey, Lakshmi Jayashankar, Robert Walker, Margaret Ann Snowden, Tom Evans, Ann Ginsberg, Steven G Reed; TBVPX-113 Study Team
